Artificial intelligence systems analyzing mammograms are detecting breast cancer up to six years earlier than traditional methods, according to new research published in medical journals this week. The AI tools identified roughly one in five breast cancer cases years before they would have been found through standard screening, offering a window for earlier intervention.
Earlier detection, better outcomes
The study used retrospective analysis of mammograms from women who were later diagnosed with breast cancer, comparing AI reads against original radiologist reports. The AI systems flagged abnormalities that were invisible to the human eye at the time. Researchers say integrating AI into routine screening could shift breast cancer detection to earlier, more treatable stages.
GLP-1 drugs and bone health
In separate health news, new data suggests GLP-1 receptor agonists — the class of drugs that includes Ozempic and Wegovy — may improve bone health in people with type 2 diabetes, not just aid weight loss. The finding adds to a growing list of potential benefits for the drugs. The FDA also proposed banning bulk compounding of semaglutide and tirzepatide, citing safety concerns about unregulated versions of the popular medications.
Menopause therapy benefits
New data also confirms that menopause hormone therapy sharply reduces the risk of low bone density and fractures in postmenopausal women, providing another tool for managing age-related bone loss.